The Federal Trade Commission’s biggest settlement to date—$1.2 billion in a pay-for-delay case—came out of federal court in Philadelphia on Thursday.
Cephalon, now owned by Teva Pharmaceutical Industries, agreed to settle a suit filed by the FTC in 2008 over the company’s reverse-payment arrangements with generic drugmakers.